Anti-CD19 CAR-T cells

DB21913InvestigationalCell transplant therapies

CD19 CAR-T is under investigation in clinical trial NCT05618041 (The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients with Hematological Malignancies).

Mechanism: Pharmacologically active on B-lymphocyte antigen CD19
Curator reviewed
Also known as: CD19 CAR T · CD19 CAR T cells · CD19 CAR T-cells · CD19 CAR-T · CD19 CAR-T cell

Resolves to

Targets

P15391CD19

What you can answer from here — as of June 26, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

154Clinical trialsPhase, status and sponsor resolved per trial

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with Anti-CD19 CAR-T cells, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account